Saudi Arabia Veterinary Medicine Market By Animal Type (Production, Companion), By Product Type (Pharmaceuticals, Vaccines, Medicated Feed Additives), By End User (Veterinary clinics, Veterinary Hospitals, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 520.91 Million
CAGR (2026-2031)	7.48%
Fastest Growing Segment	Pharmaceuticals
Largest Market	Northern & Central
Market Size (2031)	USD 803.02 Million

Market Overview

The Saudi Arabia Veterinary Medicine Market will grow from USD 520.91 Million in 2025 to USD 803.02 Million by 2031 at a 7.48% CAGR. Veterinary medicine encompasses pharmaceutical products, vaccines, medicated feed additives, and diagnostic tools employed for the prevention, treatment, and control of diseases across diverse animal species, including livestock, poultry, and companion animals. The market's growth is primarily driven by increasing demand for animal protein, rising pet ownership rates, and enhanced awareness regarding animal health and welfare. Government initiatives aimed at bolstering livestock production and ensuring food security also significantly support market expansion. According to the Saudi Press Agency, reporting on the Ministry of Environment, Water and Agriculture's 2025 achievements, the agricultural sector's GDP notably increased to SAR 118 billion.

A significant challenge that could impede market expansion is the proliferation of counterfeit veterinary products. This issue undermines the efficacy of legitimate treatments, erodes consumer trust in veterinary products, and poses considerable risks to animal health and food safety within the Kingdom.

Key Market Drivers

Rising Livestock Production Drives Veterinary Market Growth
Increased livestock production and the continuous demand for animal protein are significant drivers for the Saudi Arabia Veterinary Medicine Market. The Kingdom's focus on food security and reducing import reliance directly stimulates growth in local animal husbandry, leading to a greater need for veterinary pharmaceuticals, vaccines, and diagnostic services. As the livestock population expands, effective disease prevention and treatment become crucial to ensure animal health and productivity, ultimately safeguarding the food supply chain. This expansion supports increased spending on veterinary care for cattle, poultry, and other livestock. For instance, according to the USDA Foreign Agricultural Service, in its 'Top Produced Commodities: MY 2025/2026' report, Saudi Arabia's chicken meat production is projected to reach 1.2 million metric tons in marketing year 2025/2026, indicating substantial growth in a key livestock segment.

Growing Pet Ownership Expands Veterinary Care Demand
Concurrently, the escalating trend of pet ownership and the humanization of companion animals are profoundly influencing the veterinary medicine landscape. A cultural shift, particularly among younger demographics and urban populations, has led to pets being increasingly viewed as integral family members, prompting greater expenditure on their health and well-being. This societal change fuels demand for a wide array of veterinary services, including routine check-ups, specialized treatments, and advanced diagnostic technologies for companion animals. According to the USDA Foreign Agricultural Service, in its 'An Overview of the Pet Food Market in Saudi Arabia' report published May 07, 2025, industry sources estimated approximately 1.8 million pets were owned by residents, highlighting a sizable and growing pet population within the Kingdom. This rising demand across both livestock and companion animal sectors contributes to the market’s overall expansion, with the Saudi Arabia veterinary medicine market expected to reach $191 million in 2025, according to Saudi Agriculture.

Download Free Sample Report

Key Market Challenges

Counterfeit veterinary products undermine efficacy and consumer trust
The proliferation of counterfeit veterinary products represents a significant challenge that directly impedes the growth of the Saudi Arabia Veterinary Medicine Market. This issue critically undermines the efficacy of legitimate treatments, as fake products often contain incorrect dosages, substandard ingredients, or no active compounds, leading to ineffective disease prevention and control. Such failures erode consumer trust in veterinary products and professional services, making stakeholders hesitant to invest in officially approved medicines, vaccines, and diagnostic tools. This distrust can steer animal owners towards unverified alternatives, reducing demand for legitimate market offerings.

Health risks to animals and heightened regulatory penalties from counterfeits
Furthermore, the presence of counterfeit items poses substantial risks to animal health and subsequently to food safety within the Kingdom. Animals treated with ineffective or harmful counterfeits may suffer prolonged illness, increased mortality rates, or develop antimicrobial resistance, impacting the health of livestock, poultry, and companion animals. The economic losses for animal producers due to compromised animal health and potential regulatory actions are considerable. According to the World Agrochemicals Network Chinese website, in 2025, the Saudi Arabian Ministry of Environment, Water and Agriculture outlined severe penalties for the manufacturing or import of counterfeit pesticides, including fines up to 10 million Saudi Riyals (approximately 2.66 million US dollars), underscoring the serious financial threat posed by illicit products in related agricultural sectors. This challenge necessitates continuous vigilance and impacts the market's stability and growth trajectory.

Key Market Trends

Strengthened Zoonotic Disease Prevention and Biosecurity Investment
A significant trend shaping the Saudi Arabia Veterinary Medicine Market is the heightened emphasis on zoonotic disease prevention. This focus stems from a growing understanding of the interconnectedness of animal and human health, driving initiatives to control diseases transmissible from animals to humans. Government bodies and veterinary organizations are increasingly allocating resources towards surveillance, early detection, and vaccination programs for diseases like MERS-CoV, avian influenza, and brucellosis. These efforts necessitate a greater demand for diagnostic kits, vaccines, and specialized antimicrobial agents within the veterinary sector. According to Saudi Press Agency, July 2025, Saudi Arabia allocated a SAR 29.6 million budget towards establishing the National Excellence Center for Animal Research and Disease Control in Arar, which aims to improve veterinary services and strengthen biosecurity. This strategic investment underscores the commitment to public health through robust animal disease management, directly stimulating demand for associated veterinary products and services.

Rising Emphasis on Preventive Veterinary Care
An increased focus on preventive veterinary care is also significantly influencing the Saudi Arabia Veterinary Medicine Market. This trend reflects a shift towards proactive animal health management, aimed at minimizing disease outbreaks and enhancing overall animal well-being rather than solely treating illnesses. This proactive approach includes expanded vaccination programs, regular health screenings, and nutritional guidance for both livestock and companion animals. Such initiatives are crucial for maintaining herd health, improving productivity in animal agriculture, and reducing the economic impact of diseases. According to Saudi Agriculture, October 2026, in its exhibition report, Saudi Arabia's livestock production is expected to reach 4.5 million heads by 2026, necessitating robust preventive health strategies to safeguard this growing animal population. This emphasis drives demand for vaccines, feed supplements, and diagnostic tools designed for early detection and prevention.

Segmental Insights

Growth drivers and regulatory oversight of Saudi veterinary pharmaceuticals.
The Pharmaceuticals segment is emerging as the fastest-growing within the Saudi Arabia Veterinary Medicine Market, propelled by significant increases in both companion animal ownership and the expansion of the livestock and poultry production sectors. This surge in demand for animal protein and enhanced focus on pet well-being necessitates a robust supply of veterinary pharmaceuticals for disease prevention, control, and therapeutic treatments. Supporting this growth, the Ministry of Environment, Water and Agriculture actively promotes animal health initiatives, while the Saudi Food and Drug Authority provides crucial regulatory oversight, ensuring the quality and accessibility of these vital medical products.

Regional Insights

Northern & Central Region Leads Saudi Veterinary Medicine Market due to Urbanization, Income, and Institutional Support.
The Northern & Central region dominates the Saudi Arabia Veterinary Medicine Market, primarily due to its significant urbanization and higher population density, which drives increased pet ownership and a corresponding demand for veterinary services. This area, encompassing major economic centers such as Riyadh, benefits from higher disposable incomes enabling enhanced care for both companion animals and livestock. Moreover, the region hosts leading universities and veterinary institutions that contribute to professional expertise and sector innovation. A substantial presence of agriculture and livestock farming also necessitates consistent veterinary oversight for animal health and productivity, further solidifying the region's market leadership. Government initiatives to strengthen veterinary infrastructure also concentrate here.

Recent Developments

• In December 2025, the National Livestock and Fisheries Development Program (NLFDP) launched the Biotech Park project in Riyadh, designating it as the world's first city dedicated to veterinary biotechnology. This ambitious project aims to create a national hub that attracts leading international companies specializing in the development and localization of veterinary vaccines and products. The Biotech Park will feature a state-of-the-art laboratory and serve as a base for regional headquarters, enhancing the efficiency of Saudi Arabia's animal health system and boosting its capabilities in breakthrough veterinary research and development.
• In May 2025, Vetanco, an international animal health company, established a new partnership with Arasco, a prominent Saudi Arabian food supply and security firm, through its subsidiary Al-Emar International. Under this collaboration, Vetanco granted Al-Emar International exclusive distribution rights for its range of veterinary pharmaceutical products within Saudi Arabia. This strategic alliance aims to enhance the availability of innovative animal health solutions and contribute to the sustainable development of the agricultural sector in the Middle East, directly benefiting the Saudi Arabia veterinary medicine market.
• In September 2024, Tree Digital Insurance Agency launched Saudi Arabia's first licensed pet insurance product, offering comprehensive coverage for cats and dogs. This new product aims to provide financial protection for pet owners, covering veterinary care costs, surgeries, and medications. The introduction of such specialized insurance products is a direct response to the increasing trend of pet ownership in Saudi Arabia's urban areas and supports the growing demand for comprehensive animal healthcare solutions, significantly impacting the Saudi Arabia veterinary medicine market.
• In July 2024, the Saudi Minister of Environment, Water, and Agriculture signed a significant SAR175 million contract with a specialized national company to construct a regional reference veterinary laboratory in the Riyadh Region. This initiative is specifically designed to advance disease diagnosis and facilitate the development and localization of veterinary vaccines from local pathogenic strains. The new facility will conduct research and applied studies crucial for animal wealth and health across the Kingdom, aiming to establish itself as a regional reference for the Middle East, thereby strengthening the Saudi Arabia veterinary medicine market's research capabilities.

Key Market Players

• Zoetis Inc.
• Merck Animal Health (Merck & Co., Inc.)
• Boehringer Ingelheim Animal Health (Boehringer Ingelheim GmbH)
• Elanco Animal Health Incorporated
• Virbac S.A.
• Ceva Santé Animale
• Vetoquinol S.A.
• HIPRA (Laboratorios Hipra, S.A.)
• Phibro Animal Health Corporation
• Neogen Corporation

By Animal Type	By Product Type	By End User	By Region
Production Companion	Pharmaceuticals Vaccines Medicated Feed Additives	Veterinary clinics Veterinary Hospitals Others	Eastern Northern & Central Western Southern

Report Scope:

In this report, the Saudi Arabia Veterinary Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia Veterinary Medicine Market, By Animal Type:

• Production
• Companion

• Saudi Arabia Veterinary Medicine Market, By Product Type:

• Pharmaceuticals
• Vaccines
• Medicated Feed Additives

• Saudi Arabia Veterinary Medicine Market, By End User:

• Veterinary clinics
• Veterinary Hospitals
• Others

• Saudi Arabia Veterinary Medicine Market, By Region:

• Eastern
• Northern & Central
• Western
• Southern